# Global X Genomics & Biotechnology ETF (GNOM) — Overview

GNOM · NASDAQ · Fund

Canonical page: https://www.lighthorse.io/tickers/gnom

## Price

Last close $67.01 on Oct 15, 2026. 52-week range $41.06 – $72.30.

## Fund profile

GNOM tracks an index of global biotech equities, selected and weighted by market cap.

| Metric | Value |
| --- | --- |
| Issuer | Global X Management Company LLC |
| Industry | Theme |
| Inception | Apr 5, 2019 |
| Assets under management | $105.7M |
| Expense ratio | 0.50% |
| Net asset value | $65.85 (as of Oct 14, 2026) |
| Distributions | Semi-Annually |
| Leverage | 1x |

## Frequently Asked Questions

### What is Global X Genomics & Biotechnology ETF (GNOM)?

GNOM tracks an index of global biotech equities, selected and weighted by market cap.

### What is GNOM's expense ratio?

Global X Genomics & Biotechnology ETF charges an annual expense ratio of 0.50%. The fund is issued by Global X Management Company LLC.

### How large is GNOM?

Global X Genomics & Biotechnology ETF manages $105.7M in assets and has traded since Apr 5, 2019.

### How do I buy shares of Global X Genomics & Biotechnology ETF (GNOM)?

GNOM trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).